News
February 2025
It was with great sadness that we had to bid farewell to Prof. Dr Klaus Brandenburg on 4 February 2025.
Prof Brandenburg had worked in the Biophysics research group at the Research Centre Borstel since 1974. With his outstanding expertise and tireless research activities beyond his retirement, he made significant contributions to structural research and drug development against bacterial infections. His award-winning work has been recognised far beyond Germany's borders and has had a significant influence on research in this field.
In 2013, the spin-off from the Research Centre Borstel Leibniz Centre for Medical and Biosciences took place and Brandenburg Antiinfektiva GmbH was founded.
Prof Brandenburg was highly regarded not only as an excellent scientist, but also as an inspiring dialogue partner. With his friendly, humorous and integrative manner, he characterised every collaboration.
In Prof Brandenburg, we have lost an outstanding scientist, a valued colleague and a wonderful person.
June 2024
Glycolipid-Meeting 2023 at Hamburg University
June 2023
Glycolipid-Meeting 2023 at Hamburg University
June 2023
Aspidasept® receives Werner Petersen Innovation Award 2023
> Press release from the Research Centre Borstel, Leibniz Lung Centre
> Link to the Werner Petersen Foundation
June 2019
Glycolipid meeting at the University of Hamburg in June 2019
June 2018
Glycolipid-Meeting at Hamburg University
June 2017
Glycolipid-Meeting at Hamburg University
September 2016
Glycolipid-Meeting at Hamburg University
March 2015
Brandenburg Antiinfektiva wins Leibniz-Gründerpreis
Jury-Vorsitzender Uwe Thomas, die Preisträger Klaus Brandenburg (Brandenburg Antiinfektiva), René Bussiahn und Stephan Krafczyk (Coldplasmatech) sowie Leibniz-Präsident Matthias Kleiner (v.li.)
September 2014:
World Sepsis Day
June 2014:
Proof of antiinflammatory action in wound healing
Inhibition of the strong inflammation in blood of patients with septic shock
13th June 2014
Glycolipid-Meeting at Hamburg University
